Stanley Meresman Net Worth
The estimated Net Worth of Stanley J Meresman is at least $5.36 Million dollars as of 29 October 2019. Mr. Meresman owns over 10,000 units of Guardant Health stock worth over $730,674 and over the last 7 years he sold GH stock worth over $3,621,301. In addition, he makes $1,010,600 as Independent Director at Guardant Health.
Mr. Meresman GH stock SEC Form 4 insider trading
Stanley has made over 35 trades of the Guardant Health stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of GH stock worth $59,400 on 29 October 2019.
The largest trade he’s ever made was exercising 23,585 units of Guardant Health stock on 11 March 2015 worth over $1,524,770. On average, Stanley trades about 3,203 units every 47 days since 2012. As of 29 October 2019 he still owns at least 11,302 units of Guardant Health stock.
You can see the complete history of Mr. Meresman stock trades at the bottom of the page.
Stanley Meresman biography
Stanley J. Meresman is Independent Director of the Company. Mr. Meresman has served as a member of our board of directors since May 2018. During the last ten years, Mr. Meresman has served on the boards of directors of various public and private companies, including service as chair of the audit committee for some of these companies. He currently serves on the board of directors and as chair of the audit committee of Snap, Inc. Previously, Mr. Meresman served as a member of the board of directors, including service as chair of the audit committee, of Palo Alto Networks, Inc. from September 2014 to December 2018, LinkedIn Corporation from October 2010 to December 2016, Zynga Inc. from June 2011 to June 2015, Meru Networks, Inc. from September 2010 to May 2013, and Riverbed Technology, Inc. from March 2005 to May 2012. From January 2004 to December 2004, Mr. Meresman was a Venture Partner with Technology Crossover Ventures, a private equity firm, and was General Partner and Chief Operating Officer of Technology Crossover Ventures from November 2001 to December 2003. During the four years before joining Technology Crossover Ventures, he was a private investor and board member and adviser to several technology companies. From May 1989 to May 1997, Mr. Meresman served as the Senior Vice President and Chief Financial Officer of Silicon Graphics, Inc. Mr. Meresman holds a B.S. degree in Industrial Engineering and Operations Research from the University of California, Berkeley and an M.B.A. degree from the Stanford Graduate School of Business.
What is the salary of Stanley Meresman?
As the Independent Director of Guardant Health, the total compensation of Stanley Meresman at Guardant Health is $1,010,600. There are no executives at Guardant Health getting paid more.
How old is Stanley Meresman?
Stanley Meresman is 72, he’s been the Independent Director of Guardant Health since 2018. There are no older and 8 younger executives at Guardant Health.
What’s Stanley Meresman’s mailing address?
Stanley’s mailing address filed with the SEC is 505 PENOBSCOT DRIVE, , REDWOOD CITY, CA, 94063.
Insider trading at Guardant Health
Over the last few years, insiders at Guardant Health have traded over $539,951,735 worth of Guardant Health stock and bought 2,033,990 units worth $19,994,122 . The most active insider traders include Bluebird (Cayman) Ltd Softb…, Vision Fund (Aiv M1) L.P.Sb…, and Advisors Llc Orbimed. On average, Guardant Health executives and independent directors trade stock every 6 days with the average trade being worth of $14,665,465. The most recent stock trade was executed by Ian T Clark on 4 November 2019, trading 2,690 units of GH stock currently worth $11,244.
What does Guardant Health do?
Guardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing blood tests, vast data sets, and advanced analytics to conquer cancer. The company was founded by Helmy Eltoukhy and AmirAli H. Talasaz in 2012 and is headquartered in Redwood City, CA.
Complete history of Mr. Meresman stock trades at Zynga, Palo Alto Networks, Snap, Guardant Health, and Medallia
Guardant Health executives and stock owners
Guardant Health executives and other stock owners filed with the SEC include:
- Stanley Meresman, Independent Director
- Richard Lanman, Chief Medical Officer
- Helmy Eltoukhy, Chief Executive Officer, Director
- AmirAli Talasaz, Chairman of the Board, President, Chief Operating Officer
- Ian Clark, Lead Independent Director
- Lynn Lewis, IR Contact Officer
- Dipchand Nishar, Independent Director
- Samir Kaul, Independent Director
- Aaref Hilaly, Independent Director
- Derek Bertocci, Chief Financial Officer
- Bahija Jallal, Independent Director
- Michael Wiley, Chief Legal Officer
- Bluebird (Cayman) Ltd Softb…,
- Group Capital Ltd Softbank …,
- Us (Ttgp), Ltd.Sc U.S. Vent…,
- Vision Fund (Aiv M1) L.P.Sb…,
- Beta Pte. Ltd.Temasek Life …,
- Advisors Llc Orbimed, 10% owner
- Ultimate General Partner Se…,
- Ventures Iv, L.P.Khosla Ven…,
- Ultimate General Partner X,…,